Tirbanibulin T6345
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
KX2-391 is a highly selective Src kinase inhibitor that has demonstrated efficacy in pre-Clinicalal animal models of colon, pancreatic, prostate and breast cancer. It is a substrate-targeted kinase inhibitor. KX2-391, belongs to an emerging new family of
CAS nr:
897016-82-9
Purity:
98%
Molecular Weight:
431,53
SMILES:
C1COCCN1CCOc1ccc(cc1)c1cnc(cc1)CC(=O)NCc1ccccc1
Formula:
C26H29N3O3
Pathway:
Cytoskeletal Signaling,Tyrosine Kinase/Adaptors,Angiogenesis
Target:
Microtubule Associated,Src,Src
